National patient safety alert – harm from delayed administration of rasburicase for tumour lysis syndrome ​​

Document first published:
Page updated:
Topic:
Publication type:

This national patient safety alert has been issued by the NHS England National Patient Safety team.

It instructs all organisations providing emergency departments and cancer services to take steps to reduce the risk of harm from delayed administration of rasburicase for tumour lysis syndrome.

Link

National patient safety alert - harm from delayed administration of rasburicase for tumour lysis syndrome ​​

National patient safety alert - harm from delayed administration of rasburicase for tumour lysis syndrome ​​

NHS England is not responsible for content on external websites.

Summary

Accessible content published 9 September 2025.

Document

National patient safety alert - harm from delayed administration of rasburicase for tumour lysis syndrome ​​

National patient safety alert - harm from delayed administration of rasburicase for tumour lysis syndrome ​​

  • PDF
  • 183 KB
  • 2 pages

Summary

PDF version published 9 September 2025.